Tan et al. [35] found that AATF is overexpressed in human bladder cancer and promotes cancer progression through its regulation of cyclin E and survivin, suggesting that a potential marker and therapeutic target for bladder cancer can be identified by using AATF. The gene discussed is CCNE1; the disease is urinary bladder cancer.